Ken Griffin Bio Restorative Therapies, Inc. Transaction History
Citadel Advisors LLC
- $550 Billion
- Q2 2025
Shares
1 transactions
Others Institutions Holding BRTX
# of Institutions
18Shares Held
265KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA54.3KShares$79,7650.0% of portfolio
-
Wealth Alliance Mellville, NY40KShares$58,8000.01% of portfolio
-
Stone X Group Inc.37.7KShares$55,4830.0% of portfolio
-
Morgan Stanley New York, NY35KShares$51,4500.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.7KShares$43,7030.0% of portfolio
About BioRestorative Therapies, Inc.
- Ticker BRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 3,650,030
- Market Cap $5.37M
- Description
- BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtx...